EP1797074A4 - Composes, compositions les contenant, leur preparation et leur utilisation - Google Patents
Composes, compositions les contenant, leur preparation et leur utilisationInfo
- Publication number
- EP1797074A4 EP1797074A4 EP05784565A EP05784565A EP1797074A4 EP 1797074 A4 EP1797074 A4 EP 1797074A4 EP 05784565 A EP05784565 A EP 05784565A EP 05784565 A EP05784565 A EP 05784565A EP 1797074 A4 EP1797074 A4 EP 1797074A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- iiii
- compounds
- preparation
- compositions containing
- compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/08—Radicals containing only hydrogen and carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/GB2004/004112 WO2005030761A1 (fr) | 2003-09-26 | 2004-09-24 | Derives de benzimidazole, compositions les contenant, preparation de ces compositions et utilisations correspondantes |
SE0500267 | 2005-02-03 | ||
PCT/SE2005/001399 WO2006033627A1 (fr) | 2004-09-24 | 2005-09-22 | Composes, compositions les contenant, leur preparation et leur utilisation |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1797074A1 EP1797074A1 (fr) | 2007-06-20 |
EP1797074A4 true EP1797074A4 (fr) | 2009-04-01 |
Family
ID=36090306
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP05784565A Withdrawn EP1797074A4 (fr) | 2004-09-24 | 2005-09-22 | Composes, compositions les contenant, leur preparation et leur utilisation |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1797074A4 (fr) |
JP (1) | JP2008514589A (fr) |
WO (1) | WO2006033627A1 (fr) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE0302573D0 (sv) | 2003-09-26 | 2003-09-26 | Astrazeneca Ab | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
RU2374234C2 (ru) | 2004-09-24 | 2009-11-27 | Астразенека Аб | Бензимидазольные производные, содержащие их композиции, их получение и применение |
TW200745049A (en) | 2006-03-23 | 2007-12-16 | Astrazeneca Ab | New crystalline forms |
TW200808769A (en) | 2006-04-18 | 2008-02-16 | Astrazeneca Ab | Therapeutic compounds |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7115645B2 (en) * | 2000-01-14 | 2006-10-03 | Schering Aktiengesellschaft | 1,2 diarylbenzimidazoles and their pharmaceutical use |
SE0101387D0 (sv) * | 2001-04-20 | 2001-04-20 | Astrazeneca Ab | Novel compounds |
WO2005021547A2 (fr) * | 2003-08-28 | 2005-03-10 | Pharmaxis Pty Ltd. | Nouveaux agonistes des recepteurs cannabinoides cb2 et utilisations desdits agonistes |
SE0302570D0 (sv) * | 2003-09-26 | 2003-09-26 | Astrazeneca Ab | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
SE0302572D0 (sv) * | 2003-09-26 | 2003-09-26 | Astrazeneca Ab | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
-
2005
- 2005-09-22 WO PCT/SE2005/001399 patent/WO2006033627A1/fr active Application Filing
- 2005-09-22 EP EP05784565A patent/EP1797074A4/fr not_active Withdrawn
- 2005-09-22 JP JP2007533429A patent/JP2008514589A/ja active Pending
Non-Patent Citations (1)
Title |
---|
No further relevant documents disclosed * |
Also Published As
Publication number | Publication date |
---|---|
WO2006033627A1 (fr) | 2006-03-30 |
JP2008514589A (ja) | 2008-05-08 |
EP1797074A1 (fr) | 2007-06-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1209729A1 (en) | Compounds, compositions and methods | |
EP1730124A4 (fr) | Composes et compositions a base de triazoles et leurs applications | |
IL229778A0 (en) | Antibodies against ir-igf, their use and preparations that include them | |
IL181618A0 (en) | Pharmaceutical solid-in-oil compositions for external administraton, methods for preparation and uses thereof | |
IL191655A0 (en) | Novel compounds, their preparation and use | |
EP1742907A4 (fr) | Entites, compositions chimiques et procedes | |
IL179933A0 (en) | Pharmaceutical compositions containing proteosome based compositions | |
PT2033629E (pt) | Composição farmacêutica sólida que compreende valsartan | |
EP1962852A4 (fr) | Composes, compositions et methodes | |
IL183044A0 (en) | 2-alcoxy-3,4,5-trihydroxy-alkylamides, preparation thereof, compositions containing them and use thereof | |
IL182126A (en) | Preparations containing and used in the history of 5-phenoxyalkoxypsoralen | |
EP1797078A4 (fr) | Derives de benzimidazole, compositions contenant ces derives, preparation et utilisations de ces derniers iii | |
GB0502787D0 (en) | Pharmaceuticlly active compounds, their manufacture, compositions containing them and their use | |
IL181683A0 (en) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
ZA200705131B (en) | Solid pharmaceutical composition comprising valsartan | |
EP1797077A4 (fr) | Derives de benzimidazole, compositions contenant ces derives, preparation et utilisations de ces derniers | |
IL180316A0 (en) | Quinolone-containing medicinal composition | |
IL176993A0 (en) | Pyrroloquinoline and piperidoquinoline derivatives, preparation thereof, compositions containing them and uses thereof | |
EP1797074A4 (fr) | Composes, compositions les contenant, leur preparation et leur utilisation | |
GB0417036D0 (en) | Compounds, compositions and devices | |
GB0506496D0 (en) | Compound, composition and use | |
GB0424051D0 (en) | Compounds and compositions | |
GB2444005B (en) | Compound, composition and use | |
IL195148A0 (en) | 2-alkoxy-3,4,5-trihydroxy-alkylamide-benzazepines, the preparation and use thereof and compositions containing the same | |
GB0413209D0 (en) | Chemical composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20070424 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR |
|
DAX | Request for extension of the european patent (deleted) | ||
DA4 | Supplementary search report drawn up and despatched (deleted) | ||
17Q | First examination report despatched |
Effective date: 20090327 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20090807 |